[go: up one dir, main page]

RU2001133167A - A method for the treatment of postischemic disorders of the brain - Google Patents

A method for the treatment of postischemic disorders of the brain

Info

Publication number
RU2001133167A
RU2001133167A RU2001133167/14A RU2001133167A RU2001133167A RU 2001133167 A RU2001133167 A RU 2001133167A RU 2001133167/14 A RU2001133167/14 A RU 2001133167/14A RU 2001133167 A RU2001133167 A RU 2001133167A RU 2001133167 A RU2001133167 A RU 2001133167A
Authority
RU
Russia
Prior art keywords
brain
treatment
disorders
postischemic
administered
Prior art date
Application number
RU2001133167/14A
Other languages
Russian (ru)
Other versions
RU2217143C2 (en
Inventor
Анатолий Николаевич Кондратьев
Марат Лукманович Асланов
Екатерина Анатольевна Кондратьева
Татьяна Николаевна Фадеева
Александра Михайловна Малова
Марина Михайловна Буслаева
Фаина Михайловна Спивак
Original Assignee
Государственное учреждение "Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова"
Filing date
Publication date
Application filed by Государственное учреждение "Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова" filed Critical Государственное учреждение "Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова"
Priority to RU2001133167/14A priority Critical patent/RU2217143C2/en
Priority claimed from RU2001133167/14A external-priority patent/RU2217143C2/en
Publication of RU2001133167A publication Critical patent/RU2001133167A/en
Application granted granted Critical
Publication of RU2217143C2 publication Critical patent/RU2217143C2/en

Links

Claims (2)

1. Способ лечения постишемических нарушений функций головного мозга путем внутривенного введения холина альфосцерата, отличающийся тем, что одновременно внутривенно вводят α2-адреноагонист.1. A method of treating postischemic disorders of brain functions by intravenous administration of choline alfoscerate, characterized in that the α 2 -adrenoagonist is administered intravenously. 2. Способ по п.1, отличающийся тем, что холина альфосцерат вводят в дозе 8-10 г в сутки, а α2-адреноагонист вводят в дозе 0,4-0,6 мкг\кг\ч.2. The method according to claim 1, characterized in that choline alfoscerate is administered at a dose of 8-10 g per day, and the α 2 -adrenoagonist is administered at a dose of 0.4-0.6 μg / kg / h.
RU2001133167/14A 2001-12-06 2001-12-06 Method for treatment of post-ischemic disorders of brain functions RU2217143C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001133167/14A RU2217143C2 (en) 2001-12-06 2001-12-06 Method for treatment of post-ischemic disorders of brain functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001133167/14A RU2217143C2 (en) 2001-12-06 2001-12-06 Method for treatment of post-ischemic disorders of brain functions

Publications (2)

Publication Number Publication Date
RU2001133167A true RU2001133167A (en) 2003-08-27
RU2217143C2 RU2217143C2 (en) 2003-11-27

Family

ID=32027095

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001133167/14A RU2217143C2 (en) 2001-12-06 2001-12-06 Method for treatment of post-ischemic disorders of brain functions

Country Status (1)

Country Link
RU (1) RU2217143C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2366430C2 (en) 2007-05-23 2009-09-10 Виктор Иванович Рощин Monoaminooxidase inhibitors, therapeutic agent and pharmaceutical composition
RU2406506C1 (en) * 2009-08-17 2010-12-20 Мераб Ревазович Кокеладзе Pharmaceutical composition choline alphoscerate in form of solution for injections (cholitiline®) exhibiting nootropic activity and cholinomimetic action, method for treatment/prevention of cns diseases and effects of craniocereberal injures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2157197C1 (en) * 1999-09-15 2000-10-10 Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М. Бехтерева Method for carrying out medical rehabilitation of postinsult patients
RU2160589C1 (en) * 2000-05-18 2000-12-20 Алекс Кашлинский Agent for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome and method for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome using this agent

Similar Documents

Publication Publication Date Title
RU96115200A (en) 2,4-DISULFOFENYLBUTILNITRON, ITS SALT AND THEIR APPLICATION AS PHARMACEUTICAL SPIN TRAPS
MY136927A (en) Highly purified ethyl epa and other epa derivatives for neurological disorders
RU95114405A (en) USE OF RILUZOL AS A MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL DISORDERS CAUSED BY INJURIES AND METHOD FOR PRODUCING A MEDICINE
CA2029065A1 (en) Method of treating anxiety related disorders using sertraline
IL197890A (en) Arylvinylazacycloalkane compounds, methods of preparation and pharmaceutical compositions comprising them
RU94045278A (en) Use of 2-phenyl-3-aroylbenzothiophenes for vasomotor symptom and associated psychological disorder inhibition associated with postclimacteric syndrome
WO2006053082A3 (en) Hydroxybenzoate salts of metanicotine compounds
WO2002089805A3 (en) Use of regularly scheduled high dose intravenous methotrexate therapy
TW197423B (en)
ATE102830T1 (en) METHOD OF TREATMENT OF INTERSTITIAL BLADDER INFLAMMATION.
WO1999048489A3 (en) Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
Smeraldi et al. Fluvoxamine vs clomipramine treatment in obsessive-compulsive disorder: A preliminary study.
RU2001133167A (en) A method for the treatment of postischemic disorders of the brain
ATE285773T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
DE69926794D1 (en) PONAZURIL FOR THE TREATMENT OF DISORDERS CAUSED BY COCCIDIA NEUROLOGICAL AND "ABORTIGENIC"
EP0615750A2 (en) Treatment of a group of related disorders
RU99123225A (en) METHOD FOR TREATING SEVERE BRONCH-OBSTRUCTIVE SYNDROME IN CHILDREN OF EARLY AGE
US5081129A (en) Method of treatment of anemia with seratonin antagonists
RU96100041A (en) METHOD FOR TREATING CENTRAL NEUROLOGICAL DISORDERS IN CEREBRAL CIRCULATORY DISORDERS AND INJURIES OF THE CENTRAL NERVOUS SYSTEM
RU96103577A (en) METHOD FOR TREATING SARCOMA KAPOSHI
JP2003526659A5 (en)
PT85076A (en) Method for the treatment of infections disease by administration of tumor necrosis factor-alpha
RU98121717A (en) METHOD FOR TREATING ALLERGIC DISEASES
RU97111543A (en) METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION
DE19904365A1 (en) Xantinol nicotinate medicament useful for treating circulatory disorders, joint affections and geriatric complaints includes procaine to reduce pain on injection